Last reviewed · How we verify

Trachoma Elimination With Repeated Mass Azithromycin Treatments (TEF)

NCT00221364 Phase 4 COMPLETED

The WHO has initiated a program to eliminate blinding trachoma by the year 2020, in large part by mass oral azithromycin distributions. It is not clear how frequently or for how long these treatments are necessary. Here we assess the frequency and duration of treatment.

Details

Lead sponsorUniversity of California, San Francisco
PhasePhase 4
StatusCOMPLETED
Enrolment20000
Start date2003-03
Completion2005-04

Conditions

Interventions

Primary outcomes

Countries

Ethiopia